Company
Gate Bioscience
| Industry | biotechnology company developing a new class of small molecule medicines aiming to eliminate disease-causing proteins at their source |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Gate Bioscience | Series B | 2025-11-13 |
| Gate Bioscience | Series A Financing | 2023-11-01 |